Quanterix (QTRX) Cash from Investing Activities (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 199.36% |
| Dec 31, 2025 | 115.97% |
| Sep 30, 2025 | -185.41% |
| Jun 30, 2025 | 88.88% |
| Mar 31, 2025 | 1.17% |
| Dec 31, 2024 | 360.55% |
| Sep 30, 2024 | -278.19% |
| Jun 30, 2024 | 106.39% |
| Mar 31, 2024 | -410.83% |
| Dec 31, 2023 | 83.05% |
| Sep 30, 2023 | -15,452.53% |
| Jun 30, 2023 | -496.32% |
| Mar 31, 2023 | 91.47% |
| Dec 31, 2022 | 56.62% |
| Sep 30, 2022 | 26.56% |
| Jun 30, 2022 | -514.36% |
| Mar 31, 2022 | 63.83% |
| Dec 31, 2021 | -11.81% |
| Sep 30, 2021 | 55.85% |
| Jun 30, 2021 | -287.43% |
| Mar 31, 2021 | 59.88% |
| Dec 31, 2020 | 293.27% |
| Sep 30, 2020 | 15.72% |
| Jun 30, 2020 | -119.48% |
| Mar 31, 2020 | 21.69% |
| Dec 31, 2019 | 96.37% |
| Sep 30, 2019 | -283.39% |
| Jun 30, 2019 | 33.87% |
| Mar 31, 2019 | -5,429.91% |
| Dec 31, 2018 | 93.54% |
| Sep 30, 2018 | -584.30% |
| Jun 30, 2018 | 92.98% |
| Mar 31, 2018 | -917.40% |
| Dec 31, 2017 | -160.77% |
| Sep 30, 2017 | 73.79% |
| Jun 30, 2017 | -197.01% |